Metastatic breast cancer is stage IV (stage 4), the most advanced stage in the breast cancer staging system. It means the cancer has spread beyond the breast and nearby lymph nodes to distant parts of the body, most commonly the bones, lungs, liver, or brain. Roughly 6% of breast cancers are already metastatic at the time of first diagnosis, though metastatic disease can also develop months or years after treatment for an earlier stage.
What Makes It Stage IV
Breast cancer staging uses a system called TNM, which stands for tumor size (T), lymph node involvement (N), and whether the cancer has spread to distant sites (M). A stage IV diagnosis requires an M1 classification, meaning cancer is confirmed in at least one organ or tissue far from the breast. The size of the original tumor and the number of affected lymph nodes don’t change this. Any T, any N, combined with M1 equals stage IV.
This is different from stage III, where cancer may have spread extensively within the breast or to nearby lymph nodes but has not reached distant organs. That distinction between “nearby” and “distant” is the dividing line between stage III and stage IV.
Where It Typically Spreads
Bone is the most common site. Breast cancer cells travel through the bloodstream or lymphatic system and tend to settle in the spine, ribs, pelvis, and long bones of the arms and legs. The lungs and liver are the next most frequent locations. Spread to the brain or skin happens less often but is well documented.
Many people have metastases in more than one location at the time of diagnosis. The specific sites matter because they influence both the symptoms you experience and the treatment approach your care team recommends.
Symptoms by Location
Metastatic breast cancer can cause very different symptoms depending on where it has spread. Some people notice these symptoms before learning the cancer has traveled; others are symptom-free and learn about metastases through routine imaging.
- Bones: Sudden or worsening joint and bone pain, bones that fracture more easily than expected, numbness or weakness in the arms or legs, and swelling.
- Lungs: A persistent cough that doesn’t resolve, shortness of breath, chest pain, and frequent chest infections.
- Liver: Yellowing of the skin or eyes (jaundice), itchy skin, stomach pain, loss of appetite, and nausea.
- Brain: Worsening headaches, vision changes like blurriness or double vision, seizures, nausea, and personality or behavior changes.
How Stage IV Is Confirmed
If symptoms or earlier test results raise suspicion that breast cancer has spread, doctors typically start with a combination of imaging: a chest X-ray, a bone scan, an ultrasound of the liver, and often a CT scan. When results are unclear or something abnormal shows up, more detailed imaging follows, including MRI or PET/CT scans that can highlight areas of active cancer throughout the body.
Imaging alone isn’t always enough. Guidelines from major cancer organizations recommend biopsying a metastatic site whenever it’s safely accessible, especially the first time distant spread is detected. This confirms that the new growth is actually breast cancer and not a different cancer or a benign finding. It also checks whether the cancer’s biology has changed. Studies have repeatedly shown that the hormone receptor and HER2 status of a metastatic tumor can differ from the original breast tumor. Those differences directly affect which treatments will work, so re-testing matters.
How Treatment Goals Differ From Earlier Stages
For stages I through III, the goal of treatment is typically a cure: remove the cancer entirely and prevent it from returning. Stage IV treatment shifts focus. For most patients, the primary goals are controlling the cancer’s growth, relieving symptoms, and extending life while preserving quality of life. The cancer can often be managed for years, but it is generally considered a chronic condition rather than one with a defined endpoint of cure.
There is one notable exception. A concept called oligometastatic disease describes situations where the cancer has spread to only a small number of sites, typically five or fewer metastatic lesions in limited areas of the body. In these cases, aggressive local treatment of each metastatic spot (through surgery, radiation, or both) can sometimes push the disease into long-term remission. The idea, first proposed in the mid-1990s, is that catching distant spread early and reducing the total amount of cancer in the body can create something close to a curable situation. This approach isn’t appropriate for everyone with stage IV disease, but it represents a meaningful shift in how select patients are treated.
Survival Rates for Stage IV
The five-year relative survival rate for breast cancer that has spread to distant sites is 32.6%, based on data from the National Cancer Institute’s SEER database covering diagnoses from 2015 through 2021. That number is a population average. Individual outcomes vary widely depending on the cancer’s subtype, where it has spread, how it responds to treatment, and the person’s overall health.
It’s worth noting that survival statistics always look backward. They reflect outcomes for people diagnosed years ago, some of whom did not have access to newer treatments. Targeted therapies and antibody-drug conjugates have expanded significantly in recent years. In 2025 alone, new approvals included a drug that targets estrogen receptor-positive breast cancers with specific genetic mutations, along with new delivery methods for immunotherapy that were previously only available through IV infusion. These advances don’t show up in the current survival statistics yet, but they are changing the treatment landscape for people living with metastatic disease right now.
Stage IV Is Not Always a Late Diagnosis
A common misconception is that stage IV only happens when earlier-stage cancer is missed or undertreated. While metastatic breast cancer can develop as a recurrence after treatment for stages I through III, some people are diagnosed with distant spread from the very beginning. This is called de novo stage IV breast cancer. It means the cancer had already metastasized by the time it was first detected, regardless of screening or vigilance. The biology of certain breast cancers makes them more likely to spread early, and no amount of screening can fully eliminate that risk.